As of 2025-06-20, the Fair Value of Fusen Pharmaceutical Co Ltd (1652.HK) is -1.40 HKD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.33 HKD, the upside of Fusen Pharmaceutical Co Ltd is -522.88%.
With the market price of 0.33 HKD and our fair value calculation, Fusen Pharmaceutical Co Ltd (1652.HK) is not a good investment. Investing in 1652.HK stocks now will result in a potential loss of 522.88%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 70.13 | 16.64 | -34.60 | -36.28 | -188.78 | -34.58 |
| YoY growth | 31.25% | -76.27% | -307.90% | -4.83% | -420.39% | -155.63% |
| Market Cap (mil) | 243.97 |
| P/E | |
| Forward P/E |
| EPS | -0.26 |
| Avg earnings growth rate | -155.63% |
| TTM earnings | -188.78 |